Clinical Trials Logo

Clinical Trial Summary

In light of tigecycline's activity against these resistant bacteria, tigecycline may represent a viable new therapy for complicated intra-abdominal infections.


Clinical Trial Description

To evaluate the efficacy and safety of tigecycline to treat complicated intra-abdominal infections in hospitalized patients. Both the clinical response profile and the microbiological response profile will be assessed. The primary endpoint will be clinical response within the microbiological evaluable population at the test-of-cure assessment. ;


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00488306
Study type Interventional
Source Wyeth is now a wholly owned subsidiary of Pfizer
Contact
Status Completed
Phase Phase 4
Start date August 2006
Completion date August 2007

See also
  Status Clinical Trial Phase
Completed NCT00515034 - A Safety and Tolerability Study of Doripenem in Patients With Abdominal Infections or Pneumonia Phase 2
Recruiting NCT02688244 - Irrigation Versus Suction in Complicated Acute Appendicitis N/A
Completed NCT01568853 - A Prospective Study of The Complement Depletion in Patients With Severe Abdominal Sepsis N/A
Completed NCT00136201 - Study Comparing Tigecycline and Imipenem/Cilastatin in Chinese Subjects With Complicated Intra-Abdominal Infections Phase 3
Completed NCT00931554 - Randomized Trial of Early Versus Standard Drainage Removal After Pancreatic Resections N/A
Completed NCT03681665 - Use of Iterative Reconstruction Method in Ultralow-dose CT for Follow-up of Patients With Intraabdominal Abscess: Comparison With Standard Dose CT
Completed NCT01597336 - Treatment of Abdominal Abscesses With or Without Fibrinolysis N/A
Completed NCT01283815 - Laparoscopic Management of Periappendicular Abscess Phase 2
Completed NCT05283733 - Open to Laparoscopic Reverse Conversion of Perforated Appendicitis N/A
Completed NCT00284739 - Alteplase for Percutaneous Treatment of Loculated Abdominopelvic Abscesses Phase 2
Terminated NCT01110382 - A Safety and Tolerability Study of Doripenem Compared With Meropenem in Children Hospitalized With Complicated Intra-abdominal Infections Phase 3
Recruiting NCT03476941 - Antibiotic Irrigations for Intra-Abdominal Drains Phase 2
Recruiting NCT03815370 - A Non-Traumatic Binder for Temporary Abdominal Wall Closure N/A